“...pleasure and pain, they come and go and don't last... bear them patiently”
—Gita
Pathos InvestmentsEquity Research
Research  ›  Fact Sheets  ›  WST

WEST PHARMACEUTICAL SERVICES INC

LISTEDNYSE
SYMBOLWST
SIC3841
STATE OF INC.PA
FISCAL YEAR ENDSDecember 31
CIK105770

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2016–2025

REVENUES, NET INCOME AND FREE CASH FLOW BY FISCAL YEAR$ billions012342016201720182019202020212022202320242025RevenuesNet incomeFree cash flowEARNINGS AND DIVIDENDS PER SHARE$ per share0.002.505.007.5010.002016201720182019202020212022202320242025EPS dilutedDividends per share

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 12/31/25

($ millions)Amount%
Total debt2036.0
Stockholders' equity3,17694.0
Total capitalization3,379100.0

70,375,762 shares outstanding at 20 July 2026 (cover page of the 10-Q filed 23 July 2026).

LONG-TERM DEBT 12/31/25

($ millions)Amount
Long-term debt, incl. current maturities203
Long-term debt, noncurrent203
Current maturities0

CAPITAL STOCK 12/31/25

Common shares authorized200,000,000
Common shares issued75,300,000
Treasury shares3,300,000
Par or stated value per share ($)0.25
Preferred stock ($ millions)0
Outstanding at 7/20/2670,375,762

DIVIDENDS DECLARED/PAID

Fiscal yearPer share $Payout %
20250.8612.7
20240.8212.3
20230.789.9
20220.749.6
20210.708.1

HISTORY AND BUSINESS

HISTORY: Incorporated in Pennsylvania. Formerly known as WEST CO INC (to 11 February 1999).

BUSINESS: Classified by the SEC under Standard Industrial Classification 3841, Surgical & Medical Instruments & Apparatus. Large accelerated filer. Principal executive office: 530 Herman O. West Drive, Exton, PA 19341. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)12/31/2512/31/2412/31/23
Revenues3,0742,8932,950
Cost of revenues1,9701,8951,821
Gross profit1,1049981,129
Research and development746968
Selling, general and administrative394338353
Depreciation and amortization171155137
Operating income585570676
Interest expense039
Income before income taxes601586698
Income taxes122108122
Net income494493593
Earned per share, diluted ($)6.796.697.88
Dividends per share ($)0.860.820.78

CONSOLIDATED BALANCE SHEET

($ millions)12/31/2512/31/24
Cash and equivalents791485
Receivables, net574552
Inventories444377
Total current assets1,9781,538
Property, plant and equipment, net1,7261,582
Goodwill110106
Total assets4,2703,643
Total current liabilities655550
Long-term debt203203
Total liabilities1,094961
Stockholders' equity3,1762,682
Total liabilities and equity4,2703,643

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year endedRevenuesOper. incomeNet incomeNet margin %EPS diluted $Div. per share $Oper. cash flowCapital expend.Free cash flowTotal assetsTotal liabilitiesTotal debtStockholders' equityROE %Debt / equity
12/31/253,07458549416.16.790.867552864694,2701,0942033,17615.50.06
12/31/242,89357049317.06.690.826533772763,6439612032,68218.40.08
12/31/232,95067659320.17.880.787763624143,8309482072,88120.60.07
12/31/222,88773458620.37.730.747242854393,6179322092,68521.80.08
12/31/212,83275266223.48.670.705842533313,3149782532,33528.30.11
12/31/202,14740734616.14.570.664721742982,7949392551,85418.70.14
12/31/191,84029724213.13.210.623671262412,3417682571,57315.40.16
12/31/181,71724020712.02.740.582891051841,9795831961,39614.80.14
12/31/171,5992261519.41.990.542631311321,8635831971,28011.80.15
12/31/161,5091951449.51.910.50219170491,7175992291,11812.90.20

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

WEST PHARMACEUTICAL SERVICES INC
CIK 105770 · EIN 23-1210010

PRINCIPAL OFFICE:

530 Herman O. West Drive, Exton, PA 19341
Tel.: 6105942900

INCORPORATED:

Pennsylvania

INDUSTRY (SEC SIC CODE):

3841 · Surgical & Medical Instruments & Apparatus

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 12/31/25, filed 17 February 2026

FORMER NAMES:

WEST CO INC

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

7/23/2610-Qperiod 6/30/26
7/23/268-Kperiod 7/23/26
7/14/268-Kperiod 7/14/26
6/1/268-Kperiod 5/31/26
5/11/268-Kperiod 5/7/26
5/5/268-Kperiod 5/4/26
4/23/2610-Qperiod 3/31/26
4/23/268-Kperiod 4/23/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/17/26) · 10-K FY2024 (filed 2/18/25) · 10-K FY2023 (filed 2/20/24) · 10-K FY2022 (filed 2/21/23) · 10-K FY2021 (filed 2/22/22) · 10-K FY2020 (filed 2/23/21) · 10-K FY2019 (filed 2/24/20) · 10-K FY2018 (filed 2/28/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.

Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.

Data from SEC filings  ·  Educational only  ·  Not investment advice